References: Protocol Templates

Standard Templates
Standard protocol templates provided by the Cancer Center PRC.
Multisite: Process Flow Overview
Overview of the CTO multi-site coordination process.
Multisite: Clinical Monitoring Procedure
Template language for clinical monitoring utilizing CTO Multi-site services.
Multisite: Data Management Procedures
Template language for Data Management procedures utilizing CTO Multi-site services.
Multisite: Data Safety Monitoring Procedure
Template language for data and safety monitoring utilizing CTO Multi-site services.
Multisite: Serious Adverse Event Reporting
Template language for SAE reporting procedures utilizing CTO Multi-site services.
Multisite: Quality Assurance and Audits
Template language for quality assurance and audits utilizing CTO Multi-site services.
Multisite: Screening and Enrollment Procedures
Template language for screening and enrollment procedures utilizing CTO Multi-site services.

References: Regulatory

IRBMED: Institutional Review Board of the Medical School
The IRBMED protects the rights and welfare of human subjects, applying federal and state laws, university policies, ethical principles, particularly those articulated in the Belmont Report.
IDS: Investigational Drug Services
The goal of the IDS is to ensure that investigational drug studies and other drug related research at the Hospitals and Clinics are conducted in a safe and efficient manner.
FDA: Food and Drug Administration
FDA is responsible for protecting the public health by assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.
GCP: Good Clinical Practice in FDA-Regulated Clinical Trials
Information on the GCP issues arising in human research trials regulated by the FDA.
HIPAA: Health Insurance Portability and Accountability Act
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules 
ICH: International Conference on Harmonisation
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
UMHS Regulatory Affairs Office
UMHS Regulatory Affairs facilitates the prevention/resolution of concerns/disputes/compliance issues related to laws, regulations, institutional policies, accreditation/certification requirements, that impact the activities/reputation of the Med School.

References: Clinical

CTEP's Common Terminology Criteria for Adverse Events and Common Toxicity Criteria
Cytochrome P450 Drug Interactions Resource I
Provides a clinically relevant perspective on drugs that are affected by, or affect, cytochrome P450 (CYP) enzymes.
Cytochrome P450 Drug Interactions Resource II
Published by Indiana University, this table is designed as a hypothesis testing, teaching and reference tool for physicians and researchers interested in drug interactions that are the result of competition for, or effects on the human cytochrome P450 sys
RECIST 1.0 Guidelines
New Guidelines to Evaluate the Response to Treatment in Solid Tumors, Journal of the National Cancer Institute, 2000
RECIST 1.1 Guidelines
New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1), European Journal of Cancer, 2009
BMT Glossary
Bone Marrow Transplant terminology and definitions.
UMHS Medical Abbreviation Listing
Health Information Management's approved medical record abbreviations.
Michart 21 C.F.R. Part 11
UMHS Compliance Checklist for 21 C.F.R. Part 11 – FDA Electronic Records Closed Systems and Electronic Signatures Standards
UM Medical Equipment
UM Medical Equipment Management Plan
ECG Manual
ECG Manual GE Healthcare MAC1200
Urinalysis (Dip)
Urine result comparison with AX sticks and Trace 4+ (+,++,+++)
ECHO, Lower limit of normal documentation for the LVEF for research reporting purposes
INR Normal range documentation for research reporting purposes
UMMS Research Biorepositories Policy
University of Michigan Medical School (UMMS) Policy Governing Tissue Sample Collection, Ownership, Usage, and Disposition Within All UMMS Research Biorepositories
Response Criteria for Lymphoma
This article is reference for response criteria for lymphoma: Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007 Feb 10;25(5):579-86
RANO Criteria
Response Assessment Criteria for High-Grade Gliomas

References: Groups, Consortiums & Networks

BMT CTN: Bone Marrow Transplant Clinical Trials Network
Established because of a critical need for multi-institutional clinical trials focused directly on improving survival for patients undergoing hematopoietic cell transplantation (HCT).
EDRN: Early Detection Research Network
An initiative of the National Cancer Institute (NCI), brings together dozens of institutions to help accelerate the translation of biomarker information into clinical applications and to evaluate new ways of testing cancer in its earliest stages and for c
MMRC: Multiple Myeloma Research Consortium
Is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia.
NANT: New Approaches to Neuroblastoma Therapy (consortium)
To develop and test new therapies that will be targeted specifically to neuroblastoma cells, and therefore improve the outcome for children with advanced neuroblastoma with fewer side effects.
NCCN: National Comprehensive Cancer Network
A not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
NCI's Clinical Trails Cooperative Group Program
This program is designed to promote and support clinical trials (research studies) of new cancer treatments, explore methods of cancer prevention and early detection, and study quality-of-life issues and rehabilitation during and after treatment.
SARC: Sarcoma Alliance for Research through Collaboration
A non-profit organization dedicated to the development and support of clinical trial research for the prevention, treatment and cure of sarcomas - a cancer of the bone and connective tissue of the body
TACL:Therapeutic Advances in Childhood Leukemia (consortium)
Established to provide a means for carrying out early studies of new drugs in children with recurrent leukemia or lymphoma.

Small Text SizeMedium Text SizeLarge Text Size
Adjust text size

MCancer Research+Education

Speak with a Cancer nurse: 1-800-865-1125

Have an idea to improve the O-CTSU?
Provide us feedback.

Short Cuts